Related Experiment Video
Updated: Jan 13, 2026

15:08
Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions
Published on: October 21, 2017
10.5K
Lactate Dehydrogenase Inhibition Reverts the Fatty Acid-Induced Neurotoxic Phenotype of Astrocytes
Daniel Esteve1, Mariana Bresque1, Daniel Okhuevbie1
1Department of Neurology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Glia
|January 6, 2026
Summary
Lipid droplet accumulation in astrocytes is linked to motor neuron degeneration in amyotrophic lateral sclerosis (ALS). Inhibiting lactate dehydrogenase (LDH) reduced lipid droplets, suggesting a new therapeutic target for ALS.
Area of Science:
- Neuroscience
- Cell Biology
- Metabolic Disorders
Background:
- Astrocytes play a key role in central nervous system lipid metabolism, storing fatty acids (FAs) in lipid droplets (LD).
- Increased astrocyte LD accumulation is observed under stress and linked to mitochondrial dysfunction implicated in amyotrophic lateral sclerosis (ALS).
Purpose of the Study:
- To investigate the role of lipid metabolism and LD accumulation in astrocytes in the context of ALS.
- To explore the impact of FA overload on astrocyte-motor neuron interactions and identify potential therapeutic targets.
Main Methods:
- Analysis of LD accumulation in spinal cords of symptomatic ALS mice and human ALS-derived astrocytes.
- Co-culture models to study FA overload effects on astrocyte-motor neuron interactions.
- Pharmacological inhibition and genetic ablation of lactate dehydrogenase (LDH) and lactate dehydrogenase A (LDHA).
Main Results:
- Elevated LD observed in astrocytes from ALS mouse models and human ALS patients.
- FA overload induced astrocyte LD accumulation, coupled with a proinflammatory response and motor neuron toxicity.
- Inhibition of LDH/LDHA significantly reduced LD accumulation in ALS astrocytes.
Conclusions:
- Astrocyte LD accumulation in ALS is associated with metabolic stress and a detrimental phenotypic shift, contributing to motor neuron degeneration.
- Targeting LDH/LDHA may offer a novel therapeutic strategy for managing lipid dysregulation in ALS.

